Sfoglia per AUTORE
ROSSI G
Collezione AOU Novara

  

Items : 18

AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia. in Cancer / Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24.

2023
AOU Città della Salute di Torino
AO Cuneo
AO Ordine Mauriziano
AOU Novara

Martinelli G; Rossi G; Fumagalli M; Federico V; Marconi G; Volpi R; Sciumè M; Gigli F; Tarella C; Roncoroni E; Rivellini F; Ferrara F; Maurillo L; Nanni J; Romano A; Cardinali V; Molteni A; Martini V; Lunghi M; Fianchi L; Cilloni D; Lanza F; Cascavilla N; Abruzzese E; Gottardi M; Salutari P; Borlenghi E; Cairoli R; Manfra I; et alii...

[Not Available]. in Global & regional health technology assessment / Glob Reg Health Technol Assess. 2022 Sep 28;9:99-104. doi: 10.33393/grhta.2022.2475. eCollection 202

2022
AOU Novara

Jommi C; Apolone G; Scroccaro G; Acciai V; Addis A; Ardizzoni A; Bernardini R; Bortolami A; Brigido A; Buzzetti G; Canonico PL; Caprari F; Centanni S; Cernetti C; Cicchetti A; Corsico G; Damele F; de Braud F; Manurita S; Mennini FS; Olivi I; Parretta F; Pippo L; Pulimeno S; Riccaboni M; Rossi G; Saleri C; Sinibaldi A; Spandonaro F; et alii...

Long-term follow-up of recovered MPN patients with COVID-19. in Blood cancer journal / Blood Cancer J. 2021 Jun 16;11(6):115. doi: 10.1038/s41408-021-00509-0.

2021
AOU Città della Salute di Torino
AOU Novara

Salmoiraghi S; Rambaldi A; Bellosillo B; Guglielmelli P; Koschmieder S; Borsani O; Betti S; Benajiba L; Garrote M; Cavalca F; Curto-Garcia N; Bellini M; Daffini R; Cuevas B; Cattaneo D; Sobas MA; Xicoy Cirici B; Ruggeri M; Angona A; Hernandez-Boluda JC; Lopez Abadia E; De Stefano V; Bonifacio M; Magro Mazo E; Lunghi F; Garcia-Gutierrez V; Navas Elorza B; Benevolo G; Patriarca A; et alii...

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. in Leukemia / Leukemia. 2021 Feb;35(2):485-493. doi: 10.1038/s41375-020-01107-y. Epub 2021 Jan 7.

2021
AOU Città della Salute di Torino
AOU Novara

Betti S; Harrison C; De Stefano V; Bellini M; Bellosillo B; Benajiba L; Curto-Garcia N; Daffini R; Cavalca F; Cattaneo D; Garrote M; Cirici BX; Guglielmelli P; Abadia EL; Hernandez-Boluda JC; Cuevas B; Ruggeri M; Koschmieder S; Mazo EM; Angona A; Elorza BN; Patriarca A; Carreno-Tarragona G; Sobas MA; Lunghi F; Papadopoulos P; Bonifacio M; Cervantes KSQ; Serrano MS; et alii...

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. in Leukemia / Leukemia. 2020 Sep;34(9):2354-2363. doi: 10.1038/s41375-020-0959-x. Epub 2020 Jul 9.

2020
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Foà R; Rambaldi A; Montserrat E; Rossi G; Stamatopoulos K; Coscia M; Stavroyianni N; Strugov V; Tam C; Zdrenghea M; Shah N; Shrestha A; Stanca O; Ortiz Pareja M; Papaioannou M; Rossi D; Kalashnikova O; Hakobyan Y; Doubek M; Enrico A; Dimou M; Andres M; Chiarenza A; Nikitin E; Dos Santos G; Barna G; Yassin M; Pocali B; Sportoletti P; et alii...

Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico / Clin Transl Oncol. 2020 Sep;22(9):1603-1610. doi: 10.1007/s12094-020-02305-x. Epub 2020 Feb 11.

2020
AOU Novara

Bonaventura A; Grossi F; Carbone F; Vecchié A; Minetti S; Bardi N; Elia E; Ansaldo AM; Ferrara D; Rijavec E; Dal Bello MG; Rossi G; Biello F; Tagliamento M; Alama A; Coco S; Spallarossa P; Dallegri F; Genova C; Montecucco F;

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer. in Clinical & experimental metastasis / Clin Exp Metastasis. 2019 Oct;36(5):449-456. doi: 10.1007/s10585-019-09984-z. Epub 2019 Aug 2.

2019
AOU Novara

Carbone F; Grossi F; Bonaventura A; Vecchié A; Minetti S; Bardi N; Elia E; Ansaldo AM; Ferrara D; Rijavec E; Dal Bello MG; Biello F; Rossi G; Tagliamento M; Alama A; Coco S; Spallarossa P; Dallegri F; Genova C; Montecucco F;

Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL). in British journal of haematology / Br J Haematol. 2019 May;185(4):713-717. doi: 10.1111/bjh.15816. Epub 2019 Feb 21.

2019
AOU Città della Salute di Torino
AOU Novara

Arcaini L; Meli E; Pagani C; Nassi L; Ferrari A; Botto B; Rattotti S; Cavallo F; Marcheselli L; Anastasia A; Chiarenza A; Rusconi C; Federico M; Rossi G;

Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab. in Journal of clinical medicine / J Clin Med. 2019 Jul 10;8(7):1011. doi: 10.3390/jcm8071011.

2019
AOU Novara

Alama A; Coco S; Genova C; Rossi G; Fontana V; Tagliamento M; Giovanna Dal Bello M; Rosa A; Boccardo S; Rijavec E; Biello F; Longo L; Cavalieri Z; Bruzzo C; Grossi F;

Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus. in Immunotherapy / Immunotherapy. 2019 Jul;11(10):873-879. doi: 10.2217/imt-2019-0025. Epub 2019 Jun 3.

2019
AOU Novara

Tagliamento M; Grossi F; Paolino S; Rijavec E; Genova C; Rossi G; Biello F; De Maria A;

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2019 Aug;68(8):1351-1358. doi: 10.1007/s00262-019-02367-z. Epub 2019 Jul

2019
AOU Novara

Bonaventura A; Grossi F; Carbone F; Vecchié A; Minetti S; Bardi N; Elia E; Ansaldo AM; Ferrara D; Rijavec E; Dal Bello MG; Rossi G; Biello F; Tagliamento M; Alama A; Coco S; Spallarossa P; Dallegri F; Genova C; Montecucco F;

Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study. in Leukemia / Leukemia. 2018 Aug;32(8):1803-1807. doi: 10.1038/s41375-018-0024-1. Epub 2018 Jan 30.

2018
AOU Città della Salute di Torino
AOU Novara

Palumbo A; Lombardo A; Bertazzoni P; Rossi G; De Paoli L; Fanin R; Troia R; Patriarca F; Gaidano G; Belotti A; Spada S; Liberati AM; Cafro AM; Mina R; Bringhen S; Sonneveld P; Boccadoro M;

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study. in The Lancet. Oncology / Lancet Oncol. 2017 Aug;18(8):1076-1088. doi: 10.1016/S1470-2045(17)30444-8. Epub 2017 Jun 28.

2017
AOU Città della Salute di Torino
AOU Novara

Tucci A; Cabras MG; Congiu AG; Gotti M; Castellino A; Russo E; Cascavilla N; D'Arco A; Zaja F; Rigacci L; Pavone V; Gaidano G; Merli F; Balzarotti M; Rossi G; Stelitano C; Carella AM; Evangelista A; Brusamolino E; Angelucci E; Martelli M; Chiappella A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U;

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2016 Apr 20;34(12):1376-85. doi: 10.1200/JCO.2015.63.0699. Epub 2016 Feb 16.

2016
ASL Torino 4
AOU Città della Salute di Torino
AOU Novara

Levis A; Argnani L; Sacchetti GM; Borsatti E; Pregno P; Freilone R; Tani M; Rusconi C; Salvi F; Stelitano C; Gaidano G; Rigacci L; Pulsoni A; Pavone V; Vitolo U; Zaja F; Anastasia A; Rossi G; Brusamolino E; Bonfichi M; Ricardi U; Santoro A; Evangelista A; Ciccone G; Castagnoli A; Gioia DM; Broccoli A; Zinzani PL;

PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization. in Hematological oncology / Hematol Oncol. 2015 Sep;33(3):125-32. doi: 10.1002/hon.2148. Epub 2014 May 29.

2015
AOU Novara

Rossi G; Skert C; Morello E; Almici C; Arcaini L; Basilico C; Cavalli L; Botto B; Castelli A; Pica G; Ripamonti F; Salvi F; Carella AM; Gaidano G; Levis A; Nosari A; Russo D; Vitolo U;

Classification of different patterns of pulmonary adenocarcinomas. in Expert review of respiratory medicine / Expert Rev Respir Med. 2015 Oct;9(5):571-86. doi: 10.1586/17476348.2015.1083428. Epub 2015 Aug 27.

2015
AOU Novara

Truini A; Santos Pereira P; Cavazza A; Spagnolo P; Nosseir S; Longo L; Jukna A; Lococo F; Vincenzi G; Bogina G; Tiseo M; Rossi G;

Alveolar Pneumocytes Entrapping Pathologists. in American journal of clinical pathology / Am J Clin Pathol. 2015 Jul;144(1):174-5. doi: 10.1309/AJCPCWHLWZ8JN0OE.

2015
AOU Novara

Rossi G; Pereira-Santos P; Cavazza A;

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2014 Jun;15(7):730-7. doi: 10.1016/S1470-2045(14)70191-3. Epub 2014 May 13.

2014
AOU Città della Salute di Torino
AOU Novara

Zanni M; Ciccone G; Gaudiano M; Castellino A; Congiu A; Botto B; Dreyling M; Zaccaria A; Fattori PP; Zinzani P; Salvi F; Molinari AL; Liberati AM; Ladetto M; Pavone V; Spina M; Inghirami G; Baldi I; Carella AM; Franceschetti S; Chiappella A; Vitolo U; Gaidano G; Rossi G;